Our Leadership

Paul Wituschek is one of the most accomplished leaders and entrepreneurs in the global Pharma Services and Healthcare industries. He has served in Executive and Board roles for leading global brands, ICON Clinical Research, Catalent Pharma Solutions, Penn Pharma / PCI Pharma, Wolters Kluwer Health, and other market leading companies. During his tenures the companies generated billions in shareholder value and continuous record growth.

Leveraging his extensive network of global client, investor and industry relationships, Paul founded and is Managing Partner of Expert Insights, the world’s leading Advisory Services, Investment Research and Strategy Consulting Firm supporting investors and companies in Pharma Services, Healthcare and Life Sciences.

Paul is also CEO and Chairman of Expert Insights Ventures, a private investment fund providing capital, services and technology solutions to enable transformational growth for companies in the Pharma Services, Life Sciences and Healthcare sectors.

Paul serves on the Board of Directors at several private and publicly held companies. He is considered one the world’s leading experts on the Pharma Services industry and has advised CEOs, Boards, Investors and Companies on hundreds of value-creating deals and exits. He has completed thousands of engagements with investors, consultancies and companies across the globe and is one of the most sought-after experts in his field.

Dr. Kurt Nielsen is one of the most recognized and respected leaders in the global drug development industry. Transformational biopharmaceutical leader with over 30 years of experience in managing private and public growth businesses from small entrepreneurial to large pharma companies, as well as, developing and launching new products and drug delivery technologies, managing IP portfolios, negotiating complex transactions, including, licensing, alternative financing and M&A.

Proven leader in product launch and commercialization for specialty, oncology, anti-infective, pain, women’s health, dermatology, respiratory and cardiovascular products.

Former President & CEO of Pharmaceutics International (Pii); President, Lupin Somerset; Managing Director of Nanomi B.V.; Vice President of Development, Portfolio and Launch Management of Sandoz Inc.; Chief Technology Officer and Senior Vice President of R&D at Catalent Pharma Solutions; Board of Directors, Catalent Pharma Solutions GmbH; Executive Director of Generics, TEVA Pharmaceuticals